Immunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus Infection

BACKGROUND: Efavirenz (EFV)- and dolutegravir (DTG)-based antiretroviral therapy (ART) is the former and current recommended regimen for treatment-naive individuals with human immunodeficiency virus type 1 (HIV-1). Whether they impact the immunological and neuropsychiatric profile differentially rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Phillip, Yoon, Bohyung, Colby, Donn, Kroon, Eugène, Sacdalan, Carlo, Sriplienchan, Somchai, Pinyakorn, Suteeraporn, Ananworanich, Jintanat, Valcour, Victor, Vasan, Sandhya, Hsu, Denise, Phanuphak, Nittaya, Paul, Robert, Spudich, Serena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907536/
https://www.ncbi.nlm.nih.gov/pubmed/35687498
http://dx.doi.org/10.1093/cid/ciac466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907536/
https://www.ncbi.nlm.nih.gov/pubmed/35687498
http://dx.doi.org/10.1093/cid/ciac466

Ejemplares similares